154 related articles for article (PubMed ID: 33765502)
21. Induction of experimental autoimmune encephalomyelitis with recombinant human myelin oligodendrocyte glycoprotein in incomplete Freund's adjuvant in three non-human primate species.
Haanstra KG; Jagessar SA; Bauchet AL; Doussau M; Fovet CM; Heijmans N; Hofman SO; van Lubeek-Veth J; Bajramovic JJ; Kap YS; Laman JD; Touin H; Watroba L; Bauer J; Lachapelle F; Serguera C; 't Hart BA
J Neuroimmune Pharmacol; 2013 Dec; 8(5):1251-64. PubMed ID: 23821341
[TBL] [Abstract][Full Text] [Related]
22. Suppression of experimental allergic encephalomyelitis by transfer of lymph node cells from Lewis rats pretreated with complete Freund's adjuvant.
Englert D; Hempel K
Int Arch Allergy Appl Immunol; 1981; 66(3):326-31. PubMed ID: 6170593
[TBL] [Abstract][Full Text] [Related]
23. Endoplasmic reticulum stress response in immune cells contributes to experimental autoimmune encephalomyelitis pathogenesis in rats.
Vidicevic S; Tasic J; Stanojevic Z; Ciric D; Martinovic T; Paunovic V; Petricevic S; Tomonjic N; Isakovic A; Trajkovic V
Immunol Lett; 2024 Jun; 267():106855. PubMed ID: 38537720
[TBL] [Abstract][Full Text] [Related]
24. Allergic encephalomyelitis in the reputedly resistant Brown Norway strain of rats.
Levine S; Sowinski R
J Immunol; 1975 Feb; 114(2 Pt 1):597-601. PubMed ID: 1120901
[TBL] [Abstract][Full Text] [Related]
25. Dissection of adjuvant and suppressive effects of mycobacteria in experimental allergic encephalomyelitis production.
Mostarica-Stojković M; Vukmanović S; Petrović M; Ramić Z; Lukić ML
Int Arch Allergy Appl Immunol; 1988; 85(1):82-6. PubMed ID: 2448246
[TBL] [Abstract][Full Text] [Related]
26. Activity, but not mRNA expression of gelatinases correlates with susceptibility to experimental autoimmune encephalomyelitis.
Petković F; Živanović J; Blaževski J; Timotijević G; Momčilović M; Stanojević Ž; Stamenković V; Milošević V; Mostarica Stojković M; Miljković Đ
Neuroscience; 2015 Apr; 292():1-12. PubMed ID: 25701126
[TBL] [Abstract][Full Text] [Related]
27. Suppression of experimental allergic encephalomyelitis with thoracic duct lymphocytes.
Frost H; Swanborg RH
Int Arch Allergy Appl Immunol; 1980; 63(2):153-8. PubMed ID: 6158482
[TBL] [Abstract][Full Text] [Related]
28. Consistent induction of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice for the longitudinal study of pathology and repair.
Hasselmann JPC; Karim H; Khalaj AJ; Ghosh S; Tiwari-Woodruff SK
J Neurosci Methods; 2017 Jun; 284():71-84. PubMed ID: 28396177
[TBL] [Abstract][Full Text] [Related]
29. Oxidative damage and chemokine production dominate days before immune cell infiltration and EAE disease debut.
Hasseldam H; Rasmussen RS; Johansen FF
J Neuroinflammation; 2016 Sep; 13(1):246. PubMed ID: 27630002
[TBL] [Abstract][Full Text] [Related]
30. The innate immune response to adjuvants dictates the adaptive immune response to autoantigens.
Staykova MA; Liñares D; Fordham SA; Paridaen JT; Willenborg DO
J Neuropathol Exp Neurol; 2008 Jun; 67(6):543-54. PubMed ID: 18520773
[TBL] [Abstract][Full Text] [Related]
31. Analysis of the cellular infiltrate in the iris during experimental autoimmune encephalomyelitis.
de Vos AF; Dick AD; Klooster J; Broersma L; McMenamin PG; Kijlstra A
Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3001-10. PubMed ID: 10967057
[TBL] [Abstract][Full Text] [Related]
32. Induction of recurrent experimental allergic encephalomyelitis with myelin basic protein.
Panitch H; Ciccone C
Ann Neurol; 1981 May; 9(5):433-8. PubMed ID: 6168235
[TBL] [Abstract][Full Text] [Related]
33. Dry olive leaf extract ameliorates experimental autoimmune encephalomyelitis.
Miljković D; Dekanski D; Miljković Z; Momcilović M; Mostarica-Stojkovic M
Clin Nutr; 2009 Jun; 28(3):346-50. PubMed ID: 19386399
[TBL] [Abstract][Full Text] [Related]
34. Focal experimental autoimmune encephalomyelitis in the Lewis rat induced by immunization with myelin oligodendrocyte glycoprotein and intraspinal injection of vascular endothelial growth factor.
Sasaki M; Lankford KL; Brown RJ; Ruddle NH; Kocsis JD
Glia; 2010 Oct; 58(13):1523-31. PubMed ID: 20645414
[TBL] [Abstract][Full Text] [Related]
35. Limiting-dilution analysis of the frequency of myelin basic protein-reactive T cells in Lewis, PVG/c and BN rats. Implication for susceptibility to autoimmune encephalomyelitis.
Matsumoto Y; Kawai K; Tomita Y; Fujiwara M
Immunology; 1990 Feb; 69(2):215-21. PubMed ID: 1689693
[TBL] [Abstract][Full Text] [Related]
36. Nitric oxide and the immunomodulation of experimental allergic encephalomyelitis.
Gold DP; Schroder K; Powell HC; Kelly CJ
Eur J Immunol; 1997 Nov; 27(11):2863-9. PubMed ID: 9394811
[TBL] [Abstract][Full Text] [Related]
37.
Matsuzaki G; Teruya N; Kiyohara Kohama H; Arai K; Shibuya Y; Chuma Y; Matsuo K
Immunopharmacol Immunotoxicol; 2021 Apr; 43(2):203-211. PubMed ID: 33541144
[TBL] [Abstract][Full Text] [Related]
38. Ellagic acid protects from myelin-associated sphingolipid loss in experimental autoimmune encephalomyelitis.
Busto R; Serna J; Perianes-Cachero A; Quintana-Portillo R; García-Seisdedos D; Canfrán-Duque A; Paino CL; Lerma M; Casado ME; Martín-Hidalgo A; Arilla-Ferreiro E; Lasunción MA; Pastor Ó
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Sep; 1863(9):958-967. PubMed ID: 29793057
[TBL] [Abstract][Full Text] [Related]
39. Bioenergetics of the spinal cord in experimental autoimmune encephalitis of rats.
Al-Shamsi M; Shahin A; Ibrahim MF; Tareq S; Souid AK; Mensah-Brown EP
BMC Neurosci; 2015 Jun; 16():37. PubMed ID: 26092157
[TBL] [Abstract][Full Text] [Related]
40. Cytokine and chemokine alterations in tissue, CSF, and plasma in early presymptomatic phase of experimental allergic encephalomyelitis (EAE), in a rat model of multiple sclerosis.
Borjini N; Fernández M; Giardino L; Calzà L
J Neuroinflammation; 2016 Nov; 13(1):291. PubMed ID: 27846891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
